Wall Street Analysts See a 27.36% Upside in Protagonist Therapeutics (PTGX): Can the Stock Really Move This High?
Portfolio Pulse from
Wall Street analysts are projecting a substantial 27.36% upside for Protagonist Therapeutics (PTGX), based on current consensus price targets. The potential stock appreciation is supported by an upward trend in earnings estimate revisions, suggesting potential near-term growth for the company.
March 25, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts see significant potential in PTGX, with a 27.36% price target increase indicating positive sentiment about the company's future performance.
The strong analyst consensus and upward earnings estimate revisions suggest positive momentum for PTGX, indicating potential short-term stock price appreciation.
CONFIDENCE 75
IMPORTANCE 85
RELEVANCE 100